投資評等
最後更新日期：2024/11/1
升級(Upgrade)
| 日期/Date | 券商
Brokerage Firm | 原評等->升級後評等
Upgrade from: -> to: | 新目標價
New Target |
| 2014/11/17 | CRT Capital | Sell >> Fair Value | |
| 2012/8/28 | Ascendiant Capital Markets | Neutral >> Buy | 67 |
| 2009/10/28 | Morgan Keegan | Mkt Perform >> Outperform | |
| 2006/2/17 | Matrix Research | Sell Hold | |
| 2004/10/28 | Morgan Keegan | Mkt Perform->Outperform | |
降級(Downgrade)
| 日期/Date | 券商
Brokerage Firm | 原評等->降級後評等
Upgrade from: -> to: | 新目標價
New Target |
| 2011/5/9 | The Benchmark Company | Buy >> Hold | 90 |
| 2006/5/4 | Jefferies & Co | Hold Sell | |
| 2005/9/16 | Oppenheimer | Buy->Neutral | |
首次予以評等(Coverage Initiated)
| 日期/Date | 券商
Brokerage Firm | 原評等->升級後評等
Upgrade from: -> to: | 目標股價 |
| 2009/6/10 | Dougherty & Company | Buy | 80 |
| 2006/8/7 | Stanford Research | Sell | 40 |
| 2005/10/6 | Jefferies Co | Hold | 70 |
| 2005/6/16 | Oppenheimer | Buy | 57 |
| 2005/4/7 | Ryan, Beck Co | Outperform | 54 |
| 2005/3/9 | JMP Securities | Mkt Outperform | 60 |
恢復投資評等(Coverage Resumed)
| 日期/Date | 券商/Brokerage Firm | 恢復評等後等級/Resumed Rating | 目標股價Target |
| 查無資料 | | | |
重申相同投資評等(Coverage Reiterated)
| 日期/Date | 券商
Brokerage Firm | 重申相同投資評等
Reiterated Rating | 新目標價
New Target |
| 2012/5/15 | The Benchmark Company | Hold | $66 >> $58 |
| 2011/2/9 | Stifel Nicolaus | Buy | $100 >> $110 |
| 2011/2/9 | The Benchmark Company | Buy | $95 >> $100 |
| 2010/11/10 | Stifel Nicolaus | Buy | $90 >> $100 |
| 2009/2/10 | Stanford Research | Buy | |
| 2007/5/22 | Roth Capital | Buy | |
| 2006/5/22 | Jefferies & Co | Underperform | |
| 2006/3/31 | Ryan, Beck & Co | Outperform | |
| 2006/3/2 | JMP Securities | Mkt Outperform | |
| 2005/11/10 | Ryan, Beck Co | Outperform | 64 |